Skip to main content
PMC home page
British Journal of Pharmacology logoLink to British Journal of Pharmacology
. 1969 Nov;37(3):723–732. doi: 10.1111/j.1476-5381.1969.tb08511.x

Behavioural and somatic effects of bradykinin injected into the cerebral ventricles of unanaesthetized rabbits

F G Graeff, Irene R Pelá, M Rocha E Silva
PMCID: PMC1703715  PMID: 5388583

Abstract

1. The effects of bradykinin (1-5 μg) injected into the cannulated lateral cerebral ventricles were studied in unanaesthetized rabbits before and after intravenous atropine, diphemanil and morphine.

2. The intraventricular injections of bradykinin produced a short-lasting phase of behavioural excitation with vocalization followed by sedation. The behavioural excitation was associated with desynchronization in the electrocorticogram (e.co.g.), bradycardia and hypotension followed by tachycardia and hypertension. Tachypnoea was also observed. The subsequent phase of sedation was more prolonged and associated with synchronization of the e.co.g. and signs of catalepsy. Intense miosis was present during both phases.

3. With repeated intraventricular injections of bradykinin, excitation, miosis, cardiovascular responses and tachypnoea diminished and eventually disappeared but the sedation did not exhibit tachyphylaxis.

4. Atropine abolished the e.co.g. desynchronization, vocalization and bradycardia, reduced the duration of the excitatory and sedatory phase, diminished the tachycardia and hypotension, enhanced the hypertension, but did not affect the miosis and tachypnoea.

5. Diphemanil affected only the cardiovascular effects produced by intraventricular bradykinin. They were affected in the same way as by atropine.

6. Morphine did not affect the excitatory phase, but enhanced the cardiovascular effects produced by intraventricular bradykinin.

7. The intraventricular injection of bradykinin (50 μg) caused a reduction in the amount of noradrenaline but not of 5-hydroxytryptamine (5-HT) in the brain stem; the amount of dopamine in the caudate nuclei was not affected.

8. It is suggested that central cholinergic and adrenergic systems are activated by intraventricular bradykinin.

Full text

PDF
730

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Banerjee U., Burks T. F., Feldberg W., Goodrich C. A. Temperature effects and catalepsy produced by morphine injected into the cerebral ventricles of rabbits. Br J Pharmacol Chemother. 1968 Jul;33(3):544–551. doi: 10.1111/j.1476-5381.1968.tb00503.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Brodie B. B., Comer M. S., Costa E., Dlabac A. The role of brain serotonin in the mechanism of the central action of reserpine. J Pharmacol Exp Ther. 1966 May;152(2):340–349. [PubMed] [Google Scholar]
  3. CARLSSON A., LINDQVIST M., MAGNUSSON T. 3,4-Dihydroxyphenylalanine and 5-hydroxytryptophan as reserpine antagonists. Nature. 1957 Nov 30;180(4596):1200–1200. doi: 10.1038/1801200a0. [DOI] [PubMed] [Google Scholar]
  4. CARLSSON A., WALDECK B. A fluorimetric method for the determination of dopamine (3-hydroxytyramine). Acta Physiol Scand. 1958 Dec 15;44(3-4):293–298. doi: 10.1111/j.1748-1716.1958.tb01628.x. [DOI] [PubMed] [Google Scholar]
  5. CARPI A., PINTO CORRADO A. Cerebral vascular action of bradykinin in the dog. Experientia. 1961 Jul 15;17:326–327. doi: 10.1007/BF02158185. [DOI] [PubMed] [Google Scholar]
  6. ELLIOTT D. F., HORTON E. W., LEWIS G. P. Actions of pure bradykinin. J Physiol. 1960 Oct;153:473–480. doi: 10.1113/jphysiol.1960.sp006548. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. FERREIRA S. H. A BRADYKININ-POTENTIATING FACTOR (BPF) PRESENT IN THE VENOM OF BOTHROPS JARARCA. Br J Pharmacol Chemother. 1965 Feb;24:163–169. doi: 10.1111/j.1476-5381.1965.tb02091.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. GUZMAN F., BRAUN C., LIM R. K. Visceral pain and the pseudaffective response to intra-arterial injection of bradykinin and other algesic agents. Arch Int Pharmacodyn Ther. 1962 Apr 1;136:353–384. [PubMed] [Google Scholar]
  9. Graeff F. G., Ferreira S. H., Corrado A. P., Rocha e Silva M. Potentiation of the cerebral vascular action of bradykinin by the 'bradykinin potentiating factor' (BPF) in the dog. Experientia. 1965 Oct 15;21(10):607–608. doi: 10.1007/BF02151561. [DOI] [PubMed] [Google Scholar]
  10. Gunne L. M., Lewander T. Monoamines in brain and adrenal glands of cats after electrically induced defense reaction. Acta Physiol Scand. 1966 Jul-Aug;67(3):405–410. doi: 10.1111/j.1748-1716.1966.tb03327.x. [DOI] [PubMed] [Google Scholar]
  11. Ilyutchenok R. Y. Cholinergic brain mechanisms and behaviour. Prog Brain Res. 1968;28:134–148. doi: 10.1016/S0079-6123(08)64548-3. [DOI] [PubMed] [Google Scholar]
  12. LONGO V. G. Effects of scopolamine and atropine electroencephalographic and behavioral reactions due to hypothalamic stimulation. J Pharmacol Exp Ther. 1956 Feb;116(2):198–208. [PubMed] [Google Scholar]
  13. MEAD J. A., FINGER K. F. A single extraction method for the determination of both norepinephrine and serotonin in brain. Biochem Pharmacol. 1961 Apr;6:52–53. doi: 10.1016/0006-2952(61)90069-7. [DOI] [PubMed] [Google Scholar]
  14. RINALDI F., HIMWICH H. E. Alerting responses and actions of atropine and cholinergic drugs. AMA Arch Neurol Psychiatry. 1955 Apr;73(4):387–395. doi: 10.1001/archneurpsyc.1955.02330100019005. [DOI] [PubMed] [Google Scholar]
  15. Reis D. J., Miura M., Weinbren M., Gunne L. M. Brain catecholamines: relation to defense reaction evoked by acute brainstem transection in cat. Science. 1967 Jun 30;156(3783):1768–1770. doi: 10.1126/science.156.3783.1768. [DOI] [PubMed] [Google Scholar]
  16. SHORE P. A., OLIN J. S. Identification and chemical assay of norepinephrine in brain and other tissues. J Pharmacol Exp Ther. 1958 Mar;122(3):295–300. [PubMed] [Google Scholar]
  17. SPECTOR S., SJOERDSMA A., UDENFRIEND S. BLOCKADE OF ENDOGENOUS NOREPINEPHRINE SYNTHESIS BY ALPHA-METHYL-TYROSINE, AN INHIBITOR OF TYROSINE HYDROXYLASE. J Pharmacol Exp Ther. 1965 Jan;147:86–95. [PubMed] [Google Scholar]
  18. WIKLER A. Pharmacologic dissociation of behavior and EEG "sleep patterns" in dogs; morphine, n-allylnormorphine, and atropine. Proc Soc Exp Biol Med. 1952 Feb;79(2):261–265. doi: 10.3181/00379727-79-19345. [DOI] [PubMed] [Google Scholar]

Articles from British Journal of Pharmacology are provided here courtesy of The British Pharmacological Society

RESOURCES